Global Biopharmaceutical Logistics Market Expected to Reach US$120.7 Billion By the end 2024

Biopharmaceutical Logistics Market

PUNE, MAHARASHTRA, INDIA, September 12, 2017 /EINPresswire.com/ —

SUMMARY

Pune, India, 11 September 2017: WiseGuyReports announced addition of new report, titled “Biopharmaceutical Logistics Market (Type – Cold Chain Logistics and Non-cold Chain Logistics; Mode of Transportation – Air Shipping, Sea Shipping, Road Shipping, and Rail Shipping; Service – Transportation and Warehousing) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024”.

Logistics is a core part of any supply chain management system. Pharmaceutical industries are highly depending upon logistics because it proved great exposure to global supply chain market. Pharmaceutical sector selects the logistics for the total management of the resource for editing, storing and running the final users according to their needs. Logistics are work and support round the clock supplying various pharmaceutical products such as vaccines, antibodies, muscular cells and vendors and other bio masses in merchandise to various areas.
In recent time logistics market has observed great demand due to changes and development, proper tracking, on time delivery, good clarity and great communication help for executions. Even they provide transport for pharmaceutical industries those who do not require cold chain control. The market is also driven by due various partnership and collaboration, various ventures, merger by leading players of this market, reduce the price of packaging, a great market network which provides complete idea market flows, new packing technology and new manufacturers are various factors.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1919132-biopharmaceutical-logistics-market-type-cold-chain-logistics-and-non-cold-chain

As per research report, the Biopharmaceutical Logistics Market will grow by US$120.7 billion with CAGR of 6.2% during 2016 to 2024.
In today times, the energizing business environment and supply chain, which has been covered with more complexity, is increasing the demand for more accurate and targeted methods of temperature control. To ensure safe and reliable transport of pharmaceutical shipments, the nations of the world are following their rules. This has led to the discovery of major technologies to increase the speed of international standards for key players. Above all, Logistics is a lifeline for biopharmaceutical supply chain.
This report on the World Biopharmaceutical Logistics Market analyses current and prospects. This report contains a detailed executive summary, which includes a snapshot of the market that provides complete information about various departments and sub-departments. Research is a mixture of primary and secondary research. Detailed analysis of the factors responsible for the growth of the market and the inhibition and inclusion of the market has been given in the market observation section.

The report also helps in estimating the size of the market, related factors related to a market such as technical development, service innovation, and expansion of market infrastructure, flagship companies' warehouse network and historical year-on-year growth. The growth rate of each segment in the global biopharmaceutical market has been decided after analysing the latest trends, demographics, future trends, technological developments and regulatory requirements. These components help players in the market to make strategic decisions.
According to type, global biopharmaceutical logistics market has been divided into cold chain logistics and non-cold set logistics. Most producers need cold chain transport in the total market of cold chain market, but due to increase in biological drugs and increase in transport and due to the need for temperature-controlled soldiers, the rate of growth has increased.

Considering mode of transport for global biopharmaceutical logistics market, Air is leading mode followed by another sea, rail, road shipping. Since Air shipping is fasts way to transport with minimum damage and safety, but it has the limitation of weight. Road and sea will take lead in coming years due to tech innovation and new equipment to transport. Followed by road due to better connectivity.
Geographically, the global Biopharmaceutical Logistics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Key companies profiled in the report include FedEx Corporation, Ceva Logistics LLC, Amerisource Bergen Corporation, Panalpina Group, Kuehne + Nagel International AG, XPO Logistics, Inc., United Parcel Service, Inc., Deutsche Post DHL Group, DB Schenker and C.H. Robinson Worldwide, Inc.

About Us

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check

https://www.wiseguyreports.com/seminars

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Specialty Oleochemicals Market 2017 Share, Trend, Segmentation and Forecast to 2022

Specialty Oleochemicals Market 2017 Global Analysis, Opportunities and Forecast to 2022

PUNE, INDIA, September 12, 2017 /EINPresswire.com/ — Pune, India, 12th September 2017: WiseGuyReports announced addition of new report, titled “Global Specialty Oleochemicals Sales Market Report 2017”.

In this report, the global Specialty Oleochemicals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Specialty Oleochemicals for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2209042-global-specialty-oleochemicals-sales-market-report-2017

Global Specialty Oleochemicals market competition by top manufacturers/players, with Specialty Oleochemicals sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Vantage Specialty Chemicals
Emery Oleochemicals
Evonik Industries
Wilmar International
Cargill
TerraVia Holdings
Kao Chemicals.

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Specialty esters
Fatty acid methyl ester
Glycerol esters
Alkoxylates
Fatty amines
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Specialty Oleochemicals for each application, including
Personal care & cosmetics
Consumer goods
Food processing
Textiles
Paints & inks
Industrial
Healthcare & pharmaceuticals
Polymer & Plastic Additives
Others

Table of Content: Key Points

Global Specialty Oleochemicals Sales Market Report 2017
1 Specialty Oleochemicals Market Overview
1.1 Product Overview and Scope of Specialty Oleochemicals
1.2 Classification of Specialty Oleochemicals by Product Category
1.2.1 Global Specialty Oleochemicals Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Specialty Oleochemicals Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Specialty esters
1.2.4 Fatty acid methyl ester
1.2.5 Glycerol esters
1.2.6 Alkoxylates
1.2.7 Fatty amines
1.2.8 Others
1.3 Global Specialty Oleochemicals Market by Application/End Users
1.3.1 Global Specialty Oleochemicals Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Personal care & cosmetics
1.3.3 Consumer goods
1.3.4 Food processing
1.3.5 Textiles
1.3.6 Paints & inks
1.3.7 Industrial
1.3.8 Healthcare & pharmaceuticals
1.3.9 Polymer & Plastic Additives
1.3.10 Others
1.4 Global Specialty Oleochemicals Market by Region
1.4.1 Global Specialty Oleochemicals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Specialty Oleochemicals Status and Prospect (2012-2022)
1.4.3 China Specialty Oleochemicals Status and Prospect (2012-2022)
1.4.4 Europe Specialty Oleochemicals Status and Prospect (2012-2022)
1.4.5 Japan Specialty Oleochemicals Status and Prospect (2012-2022)
1.4.6 Southeast Asia Specialty Oleochemicals Status and Prospect (2012-2022)
1.4.7 India Specialty Oleochemicals Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Specialty Oleochemicals (2012-2022)
1.5.1 Global Specialty Oleochemicals Sales and Growth Rate (2012-2022)
1.5.2 Global Specialty Oleochemicals Revenue and Growth Rate (2012-2022)

2 Global Specialty Oleochemicals Competition by Players/Suppliers, Type and Application
2.1 Global Specialty Oleochemicals Market Competition by Players/Suppliers
2.1.1 Global Specialty Oleochemicals Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Specialty Oleochemicals Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Specialty Oleochemicals (Volume and Value) by Type
2.2.1 Global Specialty Oleochemicals Sales and Market Share by Type (2012-2017)
2.2.2 Global Specialty Oleochemicals Revenue and Market Share by Type (2012-2017)
2.3 Global Specialty Oleochemicals (Volume and Value) by Region
2.3.1 Global Specialty Oleochemicals Sales and Market Share by Region (2012-2017)
2.3.2 Global Specialty Oleochemicals Revenue and Market Share by Region (2012-2017)
2.4 Global Specialty Oleochemicals (Volume) by Application

3 United States Specialty Oleochemicals (Volume, Value and Sales Price)
3.1 United States Specialty Oleochemicals Sales and Value (2012-2017)
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2209042-global-specialty-oleochemicals-sales-market-report-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Collagen Biomaterial Market 2017 – Global Industry Key Players, Development Status, Type, Application, Forecast by 2022

Collagen Biomaterial Market

WiseGuyReports.com adds “Collagen Biomaterial Market 2017 Global Analysis, Growth, Opportunities Research Report Forecasting to 2022”reports to its database.

PUNE, INDIA, September 12, 2017 /EINPresswire.com/ — Collagen Biomaterial Market:

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Collagen Biomaterial Market on the basis of Source (Bovine, Porcine, Marine & Others), By Application (Tissue Engineering, Drug Delivery System and Others), Regulations: Opportunities and Forecasts (2017-2022), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, Mexico, U.K., Germany, China, India, Brazil and Saudi A).

Over the recent years, the global Collagen Biomaterial industry has been growing rapidly owing to aging population, rising number of people with orthopedic disorders and high demand in bone graft substitute and wound healing market. Globally, the growth in Collagen Biomaterial market is driven by increased investment in research & development.

According to Analytics research report, “Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022) – By Source (Bovine, Porcine, Marine, Others), By Application (Tissue Engineering, Drug Delivery System, Others), By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Mexico, Germany, U.K., China, India, Brazil, Saudi Arabia)”, global market is projected to display a robust growth represented by a CAGR of 9.15% during 2017 – 2022, chiefly driven by aging population and rising incidences of orthopaedic disorders.

Among the source, bovine collagen currently dominates the collagen biomaterial market. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by rising awareness about regenerative medicine, large population, rapid economic development and improvement in healthcare infrastructure.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1755653-global-collagen-biomaterial-market-analysis-by-source-by-application-by-region

The report titled “Global Collagen Biomaterial Market: Analysis By Source, By Application, By Region, By Country: Opportunities and Forecast (2017-2022) – By Source (Bovine, Porcine, Marine, Others), By Application (Tissue Engineering, Drug Delivery System, Others), By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Mexico, Germany, U.K., China, India, Brazil, Saudi Arabia)” has covered and analysed the potential of Global Neurology Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Global Collagen Biomaterial Market
By Source (Bovine, Porcine, Marine & Others)
By Application (Tissue Engineering, Drug Delivery System, Others)

Regional Markets – N. America, Europe, APAC, and ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Collagen Biomaterial Market
Collagen Biomaterial Market, By Source
Collagen Biomaterial Market, By Application

Country Analysis – US, Canada, Mexico, UK, Germany, China, India, Brazil, Saudi Arabia (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Collagen Biomaterial Market
Collagen Biomaterial Market, By Type
Collagen Biomaterial Market, By Source
Other Report Highlights

Market Dynamics – Trends, Drivers, Challenges
Policy and Regulation

Company Analysis – Collagen Solutions, Advanced BioMatrix, Collagen Matrix, Medtronic Plc, Nippi Inc, KYERON BV, EternoGen, CollPlant, Botiss Biomaterial, Cologenesis

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/1755653-global-collagen-biomaterial-market-analysis-by-source-by-application-by-region

Table of Content:

Research Methodology
Executive Summary
Strategic Recommendations 
Product Overview
Global Collagen Biomaterial Market: Growth and Forecast 
Global Collagen Biomaterials Market – Analysis By Source 
Global Collagen Biomaterials Market – Analysis By Application 
Global Collagen Biomaterial Market: Regional Analysis 
Policy and Regulatory Landscape
Market Dynamics 
Market Trends
Porter’s Five Forces Analysis
SWOT Analysis
Company Analysis 
    14.1. Collagen Solutions 
    14.2. Advanced BioMatrix 
    14.3. Medtronic Plc 
    14.4. Collagen Matrix 
    14.5. Nippi Inc. 
    14.6. KYERON BV 
    14.7. EternoGen 
    14.8. CollPlant 
    14.9. Botiss biomaterial 
    14.10. Cologenesis
About UsList of Figures
Continued…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1755653

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Cheese Saudi Arabia Market Analysis 2017 (By Segment, Key Players and Applications) and Forecasts To 2021

Cheese Saudi Arabia Market Share, Opportunities, Segmentation and Forecast to 2021

PUNE, INDIA, September 12, 2017 /EINPresswire.com/ — Pune, India, 12th September 2017: WiseGuyReports announced addition of new report, titled “Cheese (Dairy & Soy Food) Market in Saudi Arabia – Outlook to 2021: Market Size, Growth and Forecast Analytics”.

Summary
Cheese (Dairy & Soy Food) Market in Saudi Arabia – Outlook to 2021: Market Size, Growth and Forecast Analytics is a broad level market review of Cheese market in Saudi Arabia.

Cheese – all natural and processed cheese including cheese slices, grated packets of cheese, cream cheese.
Cheese market in Saudi Arabia registered a positive compound annual growth rate (CAGR) of 8.43% during the period 2011 to 2016 with a sales value of SAR 13,168.69 Million in 2016, an increase of 8.57% over 2015. The research handbook provides up-to-date market size data for period 2011-2016 and illustrative forecast to 2021 covering key market aspects like Sales Value and Volume for Cheese and its variants Natural Cheese, Processed Cheese.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2111485-cheese-dairy-soy-food-market-in-saudi-arabia-outlook-to-2021

Furthermore, the research handbook details out Sales Value for top brands for the year 2013 to 2016, Demographic Analytics and overall market sales by Distribution Channel (Hypermarkets & Supermarkets, Convenience Stores, Department Stores, Dollar Stores, Variety Store, Cash & Carries and Warehouse clubs, eRetailers, Food & Drinks specialists, Drug stores & Pharmacies, Health & Beauty Stores, Other general retailers and others) where ever applicable.

The research handbook acts as an essential tool for companies active or planning to venture in to Saudi Arabia's Cheese (Dairy & Soy Food) market. The comprehensive statistics within the research handbook provides insight into the operating environment of the market and also ensures right business decision making based on historical trends and industry model based forecasting.

Sales Values in the handbook are depicted in USD ($) and local currency of country and Volumes are represented in M Kilograms.

Scope
– Overall Cheese (Dairy & Soy Food) market value and volume analytics with growth analysis from 2011 to 2021.
– Value terms for the top brands.
– Distribution channel sales analytics from 2013-2016.

Reasons to buy
– Get access to authoritative and granular data on the Cheese (Dairy & Soy Food) market and fill in the gaps in understanding of trends and the components of change behind them.
– Enhance your understanding of the market to update your strategic and tactical plans based on volume and value changes, brand dynamics and distribution trends.
– Analyze the components of change in the market by looking at historic and future growth patterns.
– Use the data to understand future patterns of the market trends from winners and losers to category dynamics and thereby quickly and easily identify the key areas in which you want to compete in the future.

Table of Content: Key Points

1 Cheese Market Overview
2 Saudi Arabia Cheese Market Analytics, 2011-21
2.1 Cheese Value Analytics, 2011-21
2.1.1 Cheese Market by Value, 2011-21
2.1.2 Cheese Market Value by Segments, 2011-21
2.2 Cheese Volume Analytics, 2011-21
2.2.1 Cheese Market by Volume, 2011-21
2.2.2 Cheese Market Volume by Segments, 2011-21
2.3 Saudi Arabia Cheese Demographic Analytics, 2012-16
2.3.1 Saudi Arabia Cheese Demographic Analytics by Age Group, 2012-16
2.3.2 Saudi Arabia Cheese Demographic Analytics by Education Level, 2012-16
2.3.3 Saudi Arabia Cheese Demographic Analytics by Gender, 2012-16
2.3.4 Saudi Arabia Cheese Demographic Analytics by Urbanization, 2012-16
3 Saudi Arabia Cheese Market Analytics, by Segment 2011-21
3.1 Natural Cheese Analytics, 2011-21
3.1.1 Natural Cheese Market by Value, 2011-21
3.1.2 Natural Cheese Market by Volume, 2011-21
3.2 Processed Cheese Analytics, 2011-21
3.2.1 Processed Cheese Market by Value, 2011-21
3.2.2 Processed Cheese Market by Volume, 2011-21
4 Saudi Arabia Cheese Brand Analytics by Value, 2013-16
4.1 Cheese Brand Analytics by Value, 2013-16
5 Saudi Arabia Cheese Brand Analytics by Volume, 2013-16
5.1 Cheese Brand Analytics by volume, 2013-16
6 Saudi Arabia Cheese Distribution Channel Analytics by Value, 2013-16
6.1 Cheese Distribution Channel Analytics by value, 2013-16
7 Appendix
7.1 Definitions
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2111485-cheese-dairy-soy-food-market-in-saudi-arabia-outlook-to-2021

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

What Australia's bad flu season means for the United States.

Flu Season

Flu Season

The Flu Season in North America does't have a set date, but on average increases in Flu begin around October.

Influenza is categorized into two groups, the A viruses and B viruses. Although both strains can be equally severe, the A groups are typically responsible for larger outbreaks. ”

— Patrick Mansfield

KINGWOOD, TX, UNITED STATES, September 11, 2017 /EINPresswire.com/ — For Immediate Release: U.S. Health Alerts

The early flu seasons in the Northern Hemisphere are usually mostly A strains. B strains often take over later in the season. The Flu Season in North America doesn't have a set date, but on average increases in Flu begin around October.

Influenza is categorized into two groups, the A viruses and B viruses. Although both strains can be equally severe, the A groups are typically responsible for larger outbreaks. The predominant strain circulating this year has been Influenza A (H3N2). The majority (81%) of deaths this year have been due to this particular strain.

The early flu seasons in the Northern Hemisphere are usually mostly A strains. B strains often take over later in the season.

Every year, a flu vaccine featuring a combination of A and B strains is formulated for the Northern and Southern Hemisphere by a committee of scientists. To develop the vaccine, the scientists consider what strains of viruses are making people ill, how effective last year's vaccine was, and areas the viruses are spreading. Each hemisphere's vaccine can be identical or feature different strains. The vaccine formulation for the United States this year is identical to the formula that Australia is currently using.

What Does Australia's Bad Flu Season Mean for the United States?

With almost 94,000 laboratory-confirmed flu cases, Australia's flu season is turning out to be worse than usual this year. Certain groups have been particularly susceptible:
Adults over 80 years of age
Children between the ages of 5 and 9
There have been 52 confirmed deaths associated with influenza this year as compared to 27 at the same time the previous flu season. The number of influenza-related hospitalizations has also risen – 1,429 vs. 719 last year.

The highest concentration of cases, 60,000, is in New South Wales, Australia's most populous region. August turned out to be the worst flu month ever recorded in New South Wales.

Many are wondering what the bad flu season in Australia means for nations in the Northern Hemisphere such as the United States and Canada.

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases in the United States, explains that we experience a similar flu season to "what the Southern Hemisphere got in the season immediately preceding us." This could mean that the north will most likely experience a bad flu season. He notes, however, that "with influenza, it is never 100 percent".

According to Adolfo García-Sastre, a professor, and director of the Center for Research on Influenza Pathogenesis located at the Icahn School of Medicine at Mt. Sinai, the most important factor is determining what particular strain is responsible for the outbreak and if it is similar to ones that have circulated previously.

He indicates that a change in the strain may reflect a change in the makeup of the virus. Such changes can cause the virus to be more effective at causing infection and leading to a larger outbreak.

Fauci also notes that it is important to consider how many individuals were sick during the last season. If the strains that are currently circulating are the same as the previous season and relatively few individuals became sick, fewer people will have immunity and may be more susceptible to getting sick now. Alternatively, if a country had more individuals sick during the prior season, more people will be naturally immune and may not get hit as bad this season.

Symptoms of Influenza

It is important to understand and recognize the symptoms of possible influenza infection:

Fever
Chills
Headaches
Muscle aches
Congestion
Cough
Fatigue
Runny nose

The Importance of the Flu Shot:

The CDC (Centers for Disease Control) recommends that everyone six months of age or older receive the flu vaccination. Although the shots are not 100 percent effective in preventing infection, they are the best way to protect against the virus and related complications.

More Health Information On U.S. Health Alerts:

Health Outbreaks And Food Recalls
Nutrition And Wellness

Patrick Mansfield
Info Seek Media, Inc.
8329473607
email us here


Source: EIN Presswire

How to Start a Cannabis Testing Lab

Lab Scientest Examining Cannabis

Lab Scientest Examining Cannabis

Map of US State Cannabis Laws

Map of US State Cannabis Laws

Cannabis laws in the United States Legend

Cannabis laws in the United States Legend

Testing Medical Marijuana

Testing Medical Marijuana

Formaspace Casework

Formaspace Casework

Annual sales from the legal cannabis market have grown north of $1 billion in Washington State. Should you get involved and start your own cannabis testing lab?

Given the increasing consumer demand for a wide-range of cannabis-based botanical and edible products, the laboratory testing market has awoken to find a potential bonanza on their hands.”

— Formaspace

AUSTIN, TEXAS, USA, September 11, 2017 /EINPresswire.com/ — As annual sales from the legal cannabis market grow to north of $1 billion dollars in Washington State alone, many existing laboratory facilities are weighing their options on whether to jump into this rapidly expanding market by offering state-regulated cannabis test and certification services.

Ballot Initiatives Allowing Recreational Cannabis Use Find Favor among Voters in the Western States and New England

California voters approved the first legal sale of cannabis for medical purposes (commonly known as medical marijuana) in 1996. This ballot initiative conferred upon doctors the ability to prescribe cannabis to patients unable to find relief using traditional medications, including those suffering from intense pain or nausea (such as cancer patients in palliative care) or those whose chronic illnesses (such as HIV/AIDS) had led to dangerous weight loss due to lack of appetite.

Since that time, the legal cannabis market has grown rapidly.

States up and down the West Coast (including Alaska) have enacted laws expanding the medical marijuana laws to permit sales of cannabis for purely recreational purposes. This is not just a West Coast phenomenon: voters in a couple of East Coast states (Maine and Massachusetts) recently approved ballot measures allowing retail sales of cannabis for recreational use in their jurisdictions as well.

Since we last wrote about this topic, Nevada has joined other Western states that permit recreational cannabis sales. Retail sales started July 1, 2017. Within days, available supplies were exhausted as customers emptied dispensary shelves of cannabis products. Nevada’s Republican Governor, Brian Sandoval, called for additional emergency supplies to be brought into the state to satisfy the unexpectedly high demand.

To date, here are the states which have changed their laws to allow recreational cannabis sales (in addition to medical cannabis sales), along with their respective approval and implementation dates:

– Alaska (ballot initiative approved 2014, retail sales commenced February, 2015)
– California (ballot initiative approved 2016, retail sales will commence in 2018)
– Colorado (ballot initiative approved 2012, retail sales commenced January, 2014)
– Maine (ballot initiative approved 2016, retail sales commenced within 40 days)
– Massachusetts (approved 2016, retail sales will commence in July, 2018)
– Nevada (ballot initiative approved 2016, retail sales commenced July 1, 2017)
– Oregon (ballot initiative approved 2014, retail sales commenced July 1, 2015)
– Washington (ballot initiative approved 2012, retail sales commenced over 12 months)

As Demand Grows, Tax Revenues from Legal Sales of Cannabis Products Are Helping Balance State Budgets

As the demand for the product continues to grow, there are early indications that a well-managed legal cannabis market can bring in significant tax revenue to state coffers.

Take Washington State for example. As the first state to approve both medical and recreational cannabis sales, Washington has experienced tremendous growth in cannabis sales. It’s estimated that since legalization, the cumulative sales of cannabis for recreational purposes alone have already exceeded $1 billion dollars. State officials estimate that taxes and licensing fees for cannabis sales will bring over $730 million dollars in state revenue during the current two-year budget cycle.

Oregon, which has a much smaller population (4 million versus Washington State’s 7.4 million), reportedly collected $54 million in tax revenue from cannabis sales during the first 11 months of 2016.

Colorado, which began selling recreational cannabis products in January, 2014, has benefited to the tune of more than $500 million in additional tax revenue during its first two years of legalized cannabis sales. Further driving sales growth are high-profile Coloradan businesses, which have not been shy about promoting “cannabis tourism,” e.g. attracting users from neighboring states and across the country to partake in legal pot use.

(To learn more about the effect that different tax rates can have on recreational cannabis sales, visit the Tax Foundation website for an interesting analysis.)

Do You Have the In-House Expertise Necessary to Add Cannabis Test Services to Your Existing Laboratory Offerings?

As you look at the potential of the growing cannabis market, you may be asking yourself questions such as: “What steps do I need to take to add cannabis test services to my existing laboratory program?” or “What kind of personnel do I need to hire?”

Laboratory owners and managers who are contemplating the possibility of entering the market for testing and certifying consumer cannabis products will want to develop a business plan that evaluates the pluses and minuses in this rapidly evolving marketplace.

A major consideration is domain expertise. If your existing laboratory facility already handles food and beverage testing, or pharmaceutical manufacturing, or product toxicity tests in general, you’re more likely to already have the requisite laboratory experts and quality assurance technicians with the appropriate skill sets necessary to pursue opportunities in the new cannabis testing marketplace.

If, on the other hand, you are starting from scratch (by building a purpose-built laboratory) in order to enter the cannabis test and certification business, it’s most likely you’ll need to acquire personnel who have experience in establishing and maintaining Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) systems — the specifics of which will be subject to the requirements set forth by the individual state markets in which you want to enter.

Certification Rules Regulating Cannabis Testing Labs Vary State by State

One of the major disadvantages of cannabis sales being regulated by the states (rather than by the Feds) is that the rules for cannabis product testing tend to vary quite a bit from state to state.

Read more … https://formaspace.com/articles/laboratory-furniture/starting-a-cannabis-testing-lab/?utm_source=linkedin&utm_source=einpresswire&utm_medium=social&utm_medium=content&utm_campaign=article-080117&utm_campaign=article-091117&lipi=urn%3Ali%3Apage%3Ad_flagship3_company_admin%3B6s5IPngrT7qDKGULy6oIqQ%3D%3D

Kelsea Marshall
Formaspace
8002511505
email us here

What Are THC & CBD? | Marijuana


Source: EIN Presswire

Pain Relief Option Advances as the Only University-Certified Laser Practitioner Program in U.S. is Scheduled

The 12-hour on-campus program will ensure healthcare participants a high level of proficiency in the effective and safe use of drug-free therapeutic lasers

The Certified Laser Practitioner Program is a don’t-miss seminar.”

— Dr. Ralph Barrale

RICHMOND, VA, UNITED STATES, September 11, 2017 /EINPresswire.com/ — Laser therapy expert Dr. Nelson Marquina, MSc, PhD, DC will instruct the Certified Laser Practitioner Program for chiropractic and physical medicine practitioners and accompanied staff members.

The hands-on post-graduate course advances therapeutic lasers to the forefront of safe and effective medical options for addressing pain in light of the opioid addiction crisis sweeping the nation. Laser therapy uses biology, physics and technology to assist the body in healing by naturally resolving inflammation and repairing tissue at the source of pain.

USA Laser Biotech President and Chief Technology Officer, Dr. Marquina, is a developer of photonic and bioelectromagnetic systems and treatment protocols. He most recently authored a chapter in the 2017 third edition of The Scientific Basis of Integrative Health, titled, “Energy Medicine: Focus on Lasers.” The chapter provides the most relevant science as a basis for the clinical application of lasers, highlighting the capabilities of therapeutic laser light to be safely absorbed by human tissues and organs for repair and cellular regeneration.

According to Vice President of Chiropractic and Alumni Relations for Logan University, Dr. Ralph Barrale, “The Certified Laser Practitioner Program is a don’t-miss seminar. It is rare to have the opportunity to study under such a well-respected author, lecturer and acknowledged expert in the use of laser therapy, and we are excited to have Dr. Marquina back on our campus.”

The seminar program will be held in Chesterfield, Missouri on October 14–15, 2017. Early registration discount applies until September 29. Register at www.logan.edu under Alumni, call 800.842.3234 or email PostGrad@logan.edu

Deb Childs
USA Laser Biotech Inc
8774236169
email us here


Source: EIN Presswire

Motif Biosciences Unveil Novel Solutions for the Treatment Deadly Superbugs

Superbugs USA 2017

Superbugs USA 2017

New Interview Out with Motif Biosciences in the run up to their keynote address at Superbugs & Superdrugs USA this Fall

I think industry incentives are very important and the biggest challenge”

— David Huang, Chief Medical Officer at Motif Biosciences

ISELIN, NEW JERSEY, UNITED STATES, September 11, 2017 /EINPresswire.com/ — SMi Group will welcome the expertise of David Huang when he presents exclusive updates on Iclaprim, a novel diaminopyrimidine, for the treatment of serious gram- positive infections, at Superbugs & Superdrugs USA this fall. The talk will explore how Iclaprim addresses an unmet medical need in hospitalized patients with serious and life-threatening infections including MRSA.

With over 15 years of clinical, academic, industry, and research experience in medicine and in the subspecialty of infectious diseases, David Huang is Chief Medical Officer at Motif Biosciences, a clinical stage biopharmaceutical company which specializes in developing novel antibiotics.

He is currently serving as an adjunct Assistant Professor at Rutgers New Jersey Medical School and is well versed in the design, execution and close out of Phase I – III clinical trials for both antibacterial and antiviral agents. His research interests include bacteriology and virology, especially the epidemiology, pathogenesis and treatment of multidrug resistant organisms.

In the run-up to his presentation, SMi Group caught up with David to discuss current industry developments and his upcoming address this November.

From the answers provided, it is apparent that a lack of funding and strict regulatory requirements is still a common pitfall in the fight against AMR.

“I think industry incentives are very important and the biggest challenges (1) adequate government and non-government funding for the entire research and development of antibiotics; (2) strict and long regulatory requirements and timelines for developing and receiving approval for antibiotics for treatment of serious and life threatening infections; (3) awareness and education of the importance of addressing the prevention of selective pressure and in adequate use of antibiotics (animals feeds, improper use by healthcare providers, and use in developing countries without the need of prescriptions, and others); (4) reimbursements for antibiotics; (5) better and faster rapid diagnostics for all types of infections; and (6) increasing the prestige and compensation for microbiologists and infectious diseases care providers.” David Huang, Chief Medical Officer at Motif Biosciences.

The full interview in available to read in the event download centre.

Other notable speakers on the agenda will include representatives from: Janssen, BARDA, CARB-X, Pfizer, MedImmune, Visterra, Contrafect, Centauri Therapeutics, UNT Health Science Center , Microbiotix and Merck.
A detailed program and full speaker line-up is available at www.superbugs-usa.com

Superbugs & Superdrugs USA will take place on 13th & 14th November at the Renaissance Woodbrigde Hotel in Iselin, New Jersey. Sponsored by Merck and Soligenix.

— END —

Contact Information:

For all media inquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
2078276162
email us here
SMi Group


Source: EIN Presswire

Mauritanian Insurance Market Analysis 2017 (By Segment, Key Players and Applications) and Forecasts

Mauritanian Insurance Market Share, Opportunities, Segmentation and Forecast

PUNE, INDIA, September 11, 2017 /EINPresswire.com/ — Pune, India, 11th September 2017: WiseGuyReports announced addition of new report, titled “Governance, Risk and Compliance – The Mauritanian Insurance Industry”.

Synopsis
'Governance, Risk and Compliance – The Mauritanian Insurance Industry' report is the result of extensive research into the insurance regulatory framework in Mauritania.

It provides detailed analysis of the insurance regulations for life, property, motor, liability, personal accident and health, and marine, aviation and transit insurance. The report specifies various requirements for the establishment and operation of insurance and reinsurance companies and intermediaries.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1948295-governance-risk-and-compliance-the-mauritanian-insurance-industry

The report brings together research, modeling and analysis expertise, giving insurers access to information on prevailing insurance regulations, and recent and upcoming changes in the regulatory framework, taxation and legal system in the country. The report also includes the scope of non-admitted insurance in the country.

Summary
The report provides insights into the governance, risk and compliance framework pertaining to the insurance industry in Mauritania, including:

• An overview of the insurance regulatory framework in Mauritania.
• The latest key changes, and changes expected in the country’s insurance regulatory framework.
• Key regulations and market practices related to different types of insurance product in the country.
• Rules and regulations pertaining to key classes of compulsory insurance, and the scope of non-admitted insurance in Mauritania.
• Key parameters including licensing requirements, permitted foreign direct investment, minimum capital requirements, solvency and reserve requirements, and investment regulations.
• Details of the tax and legal systems in the country.

Scope
• The report covers details of the insurance regulatory framework in Mauritania.
• The report contains details of the rules and regulations governing insurance products and insurance entities.
• The report lists and analyzes key trends and developments pertaining to the country’s insurance regulatory framework.
• The report analyzes the rules and regulations pertaining to the establishment and operation of insurance businesses in the country.
• The report provides details of taxation imposed on insurance products and insurance companies.

Reasons to Buy
• Gain insights into the insurance regulatory framework in Mauritania.
• Track the latest regulatory changes, and expected changes impacting the Mauritanian insurance industry.
• Gain detailed information about the key regulations governing the establishment and operation of insurance entities in the country.
• Understand key regulations and market practices pertaining to various types of insurance product.

Key Highlights
• The Mauritanian insurance industry is regulated by the MOC.
• MTPL and workmen’s compensation are the compulsory classes of insurance.
• Composite insurance is allowed in the Mauritanian insurance industry.
• 100% foreign direct investment (FDI) is permitted in the Mauritanian insurance industry.
• Non-admitted insurance is prohibited with a few exceptions.

Table of Content: Key Points
1 INTRODUCTION
1.1 What is this Report About?
1.2 Definitions
2 GOVERNANCE, RISK AND COMPLIANCE
2.1 Legislation Overview and Historical Evolution
2.2 Latest Changes in Regulation
2.3 Legislation and Market Practice by Type of Insurance
2.3.1 Life insurance
2.3.2 Property insurance
2.3.3 Motor insurance
2.3.4 Liability insurance
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1948295-governance-risk-and-compliance-the-mauritanian-insurance-industry

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Automotive Turbochargers Market Analysis 2017 (By Segment, Key Players and Applications) and Forecasts To 2024

Automotive Turbochargers Global Market Share, Opportunities, Segmentation and Forecast to 2024

PUNE, INDIA, September 11, 2017 /EINPresswire.com/ — Market Overview
Turbocharger is a gas compressing system use to enhance the performance of engines by allowing more air at higher temperature into the engines. Turbochargers are more helpful in reducing particles in diesel engine emission and controlled (Nitrogen Oxide) NOx emissions. Additionally, turbochargers can increase fuel economy and when coupled with high pressure fuel injection makes combustion more efficient and cleaner. Automotive industry is facing challenge from rising global pressure to reduce carbon footprints and stringent fuel norms by the government. Integration of turbochargers with engines helps in addressing the growing demand for fuel efficient vehicles from consumers. Rising sales of automotives in emerging countries such as India, China and Mexico is the major factor which is driving the growth of automotive and automotive spare parts market. Asia-Pacific region is the fastest growing and largest market of automobiles in 2014; more than 7 million commercial vehicles registered in Asia-Pacific region out of which more than 3.5 million commercial vehicles were registered in China. China is the largest market for automobile industry and automobile spare parts across the globe. According to our research, it is estimated that China is going to witness vehicle sales up to 30 million units annually by 2020. Despite strict norms and strict vehicle owing restrictions in major cities of China, U.S. and The UK, automobile market is expected to grow exponentially in nearby future. The Ministry of Environmental Protection (MEP) in China states that registration of all new vehicles will have to fulfill the new vehicle standards based on policies used in Europe and United States by 2020. All new vehicles have to improve their fuel injection systems and structure of engine's combustion chamber in order to comply with new standards.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2111669-global-automotive-turbochargers-market-outlook-2024-global-opportunity-and-demand-analysis

However, innovations in technology tends to replace conventional fuel engines by electric motors and renewable energy source powered vehicles expected to hinder the growth of global automotive turbochargers market.
Market Segmentation
• By Technology Type
o Variable Geometry Turbochargers
o Twin Turbo
o Wastegate Technology
• By Vehicles Type
o Light Commercial Vehicles (LCV)
o Heavy Commercial vehicles (HCV)
o Passenger Cars
• By Fuel Type
o Diesel
o Gasoline
• By End-User
o Manufacturers (OEMs)
o Aftermarket
• By Geography
o North America (US, Canada) {Market Share (%), Market Size (USD Billion), Product Sales (Units)}
o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Product Sales (Units)}
o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Product Sales (Units)}
o Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Product Sales (Units)}
o Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Product Sales (Units)}
o Rest of the World {Market Share (%), Market Size (USD billion), Product Sales (Units)}
Market Drivers and Challenges
Properties of turbochargers to reduce fuel consumption and lower exhaust emissions are the key factors which are swelling the demand for turbochargers. Turbochargers lower the fuel consumption by 25% in diesel engines compared with similar gasoline engines. Growing demand for fuel efficient vehicles in logistic industry to increase their productivity and to overcome fuel emission norms are expected to propel the growth of global automotive turbochargers market. According to Mahle, a major automobile component manufacturer, there will be around 160 million cars and 16 million trucks running on turbochargers technology, and the affinity will continue to rise in future. Thus, turbocharger technology represents one of the largest market potential in the automotive industry across the globe. With tightening emission regulations, mature markets such as U.S and rapid-growth regions such as India and China are adopting turbocharger technology to provide cleaner transportation. The vast opportunities and rapidly growing market referred as the 'Golden Age of turbo' by the Olivier Rabiller, President and CEO of Honeywell Transportation System. Globally, diesel engines are anticipated to hold on to significant share of light vehicle sales at nearly 18%, due to their lower fuel consumption and green house gas emission. Diesel engines coupled with turbochargers provide augmented torque, range and driving experience for pickup trucks, SUVs and light commercial vehicles (LCV), which remain greater in demand. However, rising electric and hybrid cars with expected growth of 16 million units by 2021 tends to decline the growth rate of global automotive turbochargers market. Within the electric car segments, electric vehicles are expected to accounts for 14 percent; plug-in hybrids cars will account for 40%; and hybrid cars will account for 46% of the total electrified vehicles.
Market Size and Forecast (2016-2024)
According to our research, the annual sales of vehicles equipped with turbochargers are predicted to grow from 38 million units in 2016 to 59 million units by 2024, which equates to 36% increase in sales for all global industry sales. The global automotive turbochargers market accounted for USD 7.3 billion in 2015 owing to increased demand of turbocharger equipped vehicles. Global automotive turbocharger market is projected to expand at a compound annual growth rate of 6.8% over the forecast period i.e. 2016-2024 and expected to reach USD 12.4 billion by the end of 2024.
Geographically, Europe maintains its dominance over the past few years with an overall turbocharger equipped vehicles penetration of 74% in 2016. Gas turbo penetration is also expected to reach 52% by the end of 2024 owing to increase sales of light vehicles in Europe. In North-America, automotive manufacturers are working to provide twin-scroll turbo technology to extract more power from 4-cylinder exhaust profiles.

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2111669-global-automotive-turbochargers-market-outlook-2024-global-opportunity-and-demand-analysis

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire